Crossref
The Latest Topic of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) as Bofanglutide (GZR102)
International Journal of Endocrinology and Diabetes · 07.09.2026 · 9 (3) · 1-3
DOI: 10.36266/ijed/212 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Endocrinology and Diabetes, online erschienen am 07.09.2026. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). The Latest Topic of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) as Bofanglutide (GZR102). International Journal of Endocrinology and Diabetes, 9(3), 1-3. https://doi.org/10.36266/ijed/212
Vancouver
The Latest Topic of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) as Bofanglutide (GZR102). International Journal of Endocrinology and Diabetes. 2026;9(3):1-3. doi:10.36266/ijed/212
BibTeX
@article{euvimed2026,
title = {The Latest Topic of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) as Bofanglutide (GZR102)},
journal = {International Journal of Endocrinology and Diabetes},
year = {2026},
volume = {9},
number = {3},
pages = {1--3},
doi = {10.36266/ijed/212}
}
EUVIMED